Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02935400 · ClinicalTrials.gov registry record
Acute Porphyria Biomarkers for Disease Activity
A clinical trial of Acute Intermittent Porphyria and Hereditary Coproporphyria, sponsored by The University of Texas Medical Branch, Galveston.
- Active
- Registry status
- 50
- Enrollment target
- 1
- Study location
NCT02935400: Active study of Acute Intermittent Porphyria and Hereditary Coproporphyria, sponsored by The University of Texas Medical Branch, Galveston.
NCT02935400 is a study of Acute Intermittent Porphyria and Hereditary Coproporphyria that is active but no longer recruiting, run by The University of Texas Medical Branch, Galveston. The registered enrollment target is 50 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02935400, a study of Acute Intermittent Porphyria and Hereditary Coproporphyria, is active but no longer recruiting, sponsored by The University of Texas Medical Branch, Galveston.
- ACTIVE NOT RECRUITING
- Registry status
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
The long term objective of the research is to identify new biomarkers of disease activity in the human acute porphyrias. This pilot study is intended to provide pilot and feasibility data needed to plan larger and more definitive future studies.
Primary Outcome
Expression of heme biosynthetic and heat and stress response genes
Conditions Studied
Interventions
- DRUG Hemin
Study Locations (1)
Texas
- University of Texas Medical Branch - Galveston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2014-04-28 |
| Est. Completion | 2026-12-31 |
What the registry record for NCT02935400 still lists
NCT02935400 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 50 participants, a relatively small participant target.
The record links to 3 conditions, with Acute Intermittent Porphyria appearing as the primary indexed condition, and to 1 intervention - of which Hemin is the first listed.
NCT02935400 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT02935400 about?
NCT02935400 is a clinical study titled "Acute Porphyria Biomarkers for Disease Activity". The long term objective of the research is to identify new biomarkers of disease activity in the human acute porphyrias. This pilot study is intended to provide pilot and feasibility data needed to plan larger and more definitive future studies.
What is the current status of trial NCT02935400?
This trial is currently active not recruiting. The enrollment target is 50 participants. The study started on 2014-04-28. Estimated completion is 2026-12-31.
What conditions does trial NCT02935400 study?
This clinical trial studies the following conditions: Acute Intermittent Porphyria, Hereditary Coproporphyria, Variegate Porphyria.
What interventions are being tested in trial NCT02935400?
The interventions under investigation include: Hemin (DRUG).
Who is sponsoring clinical trial NCT02935400?
This trial is sponsored by The University of Texas Medical Branch, Galveston, which has 203 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02935400 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acute Intermittent Porphyria
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI